SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-16-023077
Filing Date
2016-04-15
Accepted
2016-04-15 07:43:41
Documents
1
Period of Report
2016-04-12

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 8355
  Complete submission text file 0001179110-16-023077.txt   9690
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Issuer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 57 OPOSSUM RD SKILLMAN NJ 08558
Business Address
Hopper Jonathan Mark (Reporting) CIK: 0001626325 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-32966 | Film No.: 161573170